Stryker Corporation Stryker Corporation

Stryker Corporation

SYK

주식 순위 #190
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
주가
$304.72
마지막 동기화: 2026-10-20
시가총액
$116.88B
변동 (1일)
1.96%
변동 (1년)
-19.76%
국가
US
거래 Stryker Corporation (SYK)

카테고리

Healthcare
Stryker Corporation (SYK)의 매출
Jun 2026 기준 매출 TTM: $25.84B
Stryker Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $25.84B입니다. 2024년에 회사는 $22.60B의 수익을 올렸으며 이는 2023년의 $20.50B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Stryker Corporation의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $25.84B 2.87%
2025 $25.12B 11.16%
2024 $22.60B 10.23%
2023 $20.50B 11.11%
2022 $18.45B 7.84%
2021 $17.11B 19.21%
2020 $14.35B -3.58%
2019 $14.88B 9.43%
2018 $13.60B 9.30%
2017 $12.44B 9.88%
2016 $11.33B 13.86%
2015 $9.95B 2.80%
2014 $9.68B 7.25%
2013 $9.02B 4.20%
2012 $8.66B 4.21%
2011 $8.31B 13.48%
2010 $7.32B 8.88%
2009 $6.72B 0.07%
2008 $6.72B 11.96%
2007 $6.00B 11.01%
2006 $5.41B 10.96%
2005 $4.87B 14.29%
2004 $4.26B 17.57%
2003 $3.63B 20.38%
2002 $3.01B 15.73%
2001 $2.60B 13.67%
2000 $2.29B 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$46.59B 80.30%
US
$35.48B 37.34%
IE
$21.00B -18.74%
US
- -
DE
$6.51B -74.79%
US